COVID-19 related acute necrotizing encephalopathy presenting in the early postoperative period
Abstract
##plugins.themes.bootstrap3.article.details##
neuroimaging diagnosis, case report, acute hemorrhagic necrotizing encephalopathy, neurologic manifestations, covid-19, prompt treatment
2. Divani AA, Andalib S, Biller J, et al. Central Nervous System Manifestations Associated with COVID-19. Curr Neurol Neurosci Rep. 2020;20(12):60. doi: 10.1007/s11910-020-01079-7. Erratum in: Curr Neurol Neurosci Rep. 2020;20(12):66. PMID: 33128130; PMCID: PMC7599061.
3. Nazari S, Azari Jafari A, Mirmoeeni S, et al. Central nervous system manifestations in COVID-19 patients: A systematic review and meta-analysis. Brain Behav. 2021;11(5):e02025. doi: 10.1002/brb3.2025. PMID: 33421351; PMCID: PMC7994971.
4. Giorgianni A, Vinacci G, Agosti E, et al. Transient acute-onset tetraparesis in a COVID-19 patient. Spinal Cord. 2020;58(9):1042-1044. doi: 10.1038/s41393-020-0493-8. Erratum in: Spinal Cord. 2020: PMID: 32488194; PMCID: PMC7264484.
5. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020;296(2):E119-E120. doi: 10.1148/radiol.2020201187. PMID: 32228363; PMCID: PMC7233386.
6. Jomaa N, El Halabi T, Melhem J, et al. COVID-19-Associated Acute Asymmetric Hemorrhagic Necrotizing Encephalopathy: A Case Report. Neurohospitalist. 2022;12(2):371-376. doi: 10.1177/19418744211055360. PMID: 35401914; PMCID: PMC8977755.
7. Garg RK, Paliwal VK, Malhotra HS, Sharma PK. Neuroimaging Patterns in Patients with COVID-19-Associated Neurological Complications: A Review. Neurol India. 2021;69(2):260-271. doi: 10.4103/0028-3886.314531. PMID: 33904434.
8. Bansal P, Fory EK, Malik S, Memon AB. Clinical Course of a Patient with Radiographically Described Acute Necrotizing Encephalopathy. Radiology. 2020;297(2):E278-E280. DOI: 10.1148/radiol.2020203132. PMID: 32787703; PMCID: PMC7427117.
9. Gadani S, Cohen A. Acute Necrotizing Encephalitis as an Early Manifestation of COVID-19. Cureus. 2022;14(8):e27928. doi: 10.7759/cureus.27928. PMID: 36120249; PMCID: PMC9464457.
10. Alqahtani A, Alaklabi A, Kristjansson S, et al. Acute necrotic hemorrhagic leukoencephalitis related to COVID-19: a report of 2 cases. Radiol Case Rep. 2021;16(9):2393-2398. doi: 10.1016/j.radcr.2021.05.072. PMID: 34104284; PMCID: PMC8173541.
11. Ray S, Kamath VV, Raju PA, Kn R, N S. Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection. J Stroke Cerebrovasc Dis. 2022;31(2):106238. doi: 10.1016/j.jstrokecerebrovasdis.2021.106238. PMID: 34915308; PMCID: PMC8616734.
12. Mousa H, Patel TH, Meadows I, Ozdemir B. Acute Disseminated Encephalomyelitis (ADEM) After Consecutive Exposures to Mycoplasma and COVID Vaccine: A Case Report. Cureus. 2022;14(6):e26258. doi: 10.7759/cureus.26258. PMID: 35911280; PMCID: PMC9312359.
13. Parsons T, Banks S, Bae C, et al. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020;267(10):2799-2802. doi: 10.1007/s00415-020-09951-9. PMID: 32474657; PMCID: PMC7260459.
14. Miller TE, Garcia Beltran WF, Bard AZ, et al. Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital. FASEB J. 2020;34(10):13877-13884. doi: 10.1096/fj.202001700RR. PMID: 32856766; PMCID: PMC7461169.
15. Anka AU, Tahir MI, Abubakar SD, et al. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management. Scand J Immunol. 2021;93(4):e12998. doi: 10.1111/sji.12998. PMID: 33190302; PMCID: PMC7744910.
16. Sterlin D, Mathian A, Miyara M, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13(577):eabd2223. doi: 10.1126/scitranslmed.abd2223. PMID: 33288662; PMCID: PMC7857408.
17. Zervou FN, Louie P, Stachel A, et al. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol. 2021;93(9):5409-5415. doi: 10.1002/jmv.27058. PMID: 33932299; PMCID: PMC8242647.
18. Cervia C, Nilsson J, Zurbuchen Y, et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol. 2021;147(2):545-557.e9. doi: 10.1016/j.jaci.2020.10.040. PMID: 33221383; PMCID: PMC7677074.
19. Adjobimey T, Meyer J, Sollberg L, et al. Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines. Front Immunol. 2022;13:917905. doi: 10.3389/fimmu.2022.917905. PMID: 35799790; PMCID: PMC9254618.
20. Al-Tamimi M, Tarifi AA, Qaqish A, et al. Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals. PLoS One. 2023;18(2):e0281689. doi: 10.1371/journal.pone.0281689. PMID: 36787317; PMCID: PMC9928079.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.